Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

pseudopseudohypoparathyroidism/obesity

リンクがクリップボードに保存されます
ページ 1 から 30 結果
BACKGROUND Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein alpha-subunit Galpha(s). Because Galpha(s) is paternally imprinted in certain hormone target tissues, maternal inheritance of

Pseudo-pseudohypoparathyroidism: report of a case with associated cardiopulmonary syndrome of obesity.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND Pseudohypoparathyroidism type Ia and pseudopseudohypoparathyroidism are characterized by Albright's hereditary osteodystrophy (AHO), respectively, with and without hormone resistance. Both clinical conditions result from decreased expression or function of the alpha-subunit of the

Early manifestation of obesity and calcinosis cutis in infantile pseudohypoparathyroidism.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Pseudohypoparathyroidism is a parathyroid hormone resistance condition, characterised by biochemical findings of hypocalcaemia or normocalcaemia with inappropriately elevated parathyroid hormone level and usually with a typical osteodystrophy feature. We report an infant with

[Pseudopseudohypoparathyroidism and genomic imprinting].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Pseudopseudohypoparathyroidism (PPHP) is caused by the paternally-derived mutation in the coding region of GNAS gene. The phenotype of PPHP is produced by the sum of both decreased Gsalpha protein in biallelically expressed tissues and other proteins or non-coding RNAs by mutated paternal-allele

Bariatric surgery in an obese patient with Albright hereditary osteodystrophy: a case report.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND We report for the first time the case of a patient with Albright hereditary osteodystrophy and pseudopseudohypoparathyroidism who underwent a Roux-en-Y gastric bypass. METHODS A 26-year-old obese Caucasian woman with Albright hereditary osteodystrophy with pseudopseudohypoparathyroidism

Definable somatic disorders in overweight children and adolescents.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
OBJECTIVE To analyze the frequencies and clinical presentation of definable somatic disorders in children who are overweight. METHODS We assessed prospectively 1405 children aged 4 to 16 years who were overweight and came to our specialized clinic for endocrinology and obesity with a standardized

Linear skin atrophy preceding calcinosis cutis in pseudo-pseudohypoparathyroidism.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Albright hereditary osteodystrophy (AHO) is a syndrome caused by inactivating mutations in the GNAS (guanine nucleotide-binding protein, alpha-stimulating) gene. Patients with AHO have short stature, obesity, brachydactyly and subcutaneous calcifications. AHO can be associated with

Osteoma cutis as the presenting feature of albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Primary osteoma cutis is characterized by the formation of normal bone tissue in the dermis or subcutis without any underlying tissue abnormality or pre-existing calcification. This illness is associated with Albright hereditary osteodystrophy (AHO), which is characterized by such physical features

Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND Loss-of-function GNAS mutations lead to hormone resistance and Albright's hereditary osteodystrophy (AHO) when maternally inherited, i.e. pseudohypoparathyroidism-Ia (PHPIa), but cause AHO alone when located on the paternal allele, i.e. pseudoPHP (PPHP). OBJECTIVE We aimed to establish

Brachydactyly mental retardation syndrome in differential diagnosis of pseudopseudohypoparathyroidism.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Patients with Albright hereditary osteodystrophy (AHO) phenotype are usually seen in pediatric endocrinology policlinics when they are evaluated for short stature and/or obesity. Brachydactyly mental retardation syndrome (BDMR, OMIM #600430) is a rare genetic disorder caused by aberrations of

Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
OBJECTIVE Given that tricho-rhino-phalangeal syndrome (TRPS) and pseudohypoparathyroidism/pseudopseudohypoparathyroidism (PHP/PPHP) are very rare monogenic disorders that share some features (distinctive facies, short stature, brachydactyly and, in some patients, intellectual disability) that lead

Polyglandular Autoimmune Syndrome Type III with Primary Hypoparathyroidism.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Polyglandular autoimmune syndrome is defined as multiple endocrine gland insufficiencies accompanied by autoimmune diseases of the endocrine and nonendocrine system. After Schmidt introduced a case of nontuberculosis adrenal gland dysfunction with thyroiditis in 1926, Neufeld defined polyglandular

Familial Albright's hereditary osteodystrophy with hypoparathyroidism: normal structural Gs alpha gene.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Albright's hereditary osteodystrophy (AHO) is a characteristic skeletal phenotype, including short stature, obesity, round face, and brachydactyly. AHO appears in patients with pseudohypoparathyroidism (PHP) who have resistance to PTH and in their eumetabolic family members who have
OBJECTIVE To identify the molecular defect by which psychomotor retardation is caused in two brothers with congenital hypothyroidism who received adequate treatment with l-thyroxine. METHODS A six-year-old boy presented with psychomotor retardation and congenital primary hypothyroidism (CH). The
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge